Experience

Spirify Pharma, Inc.

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chief Executive Officer

  • Aug 2019 - Present

  Spirify Pharma is developing a new family of non-addictive ketamine-derived drugs for the treatment of depression and pain. Our family of molecules provide a wide choice of drugs addressing various indications, to replace bad drugs that have been out there for so many years. Spirify Pharma is developing a new family of non-addictive ketamine-derived drugs for the treatment of depression and pain. Our family of molecules provide a wide choice of drugs addressing various indications, to replace bad drugs that have been out there for so many years.



MigVax Ltd.

• Israel

• Chief Clinical and Regulatory Officer

  • Mar 2020 - Present

  MigVax is developing an oral subunit vaccine for COVID-19. Humanity has never faced such a challenge - develop a vaccine within 18 months! MigVax team has combined decades of track record with successful global vaccine and pharmaceutical achievements. MigVax is developing an oral subunit vaccine for COVID-19. Humanity has never faced such a challenge - develop a vaccine within 18 months! MigVax team has combined decades of track record with successful global vaccine and pharmaceutical achievements.



t-syte Ltd.

• Israel
• Investment Management
• 1 - 100 Employee

• Chief Medical Officer

  • Nov 2019 - Present

  T-syte is an Israeli Healthcare Venture Lab focused on Digital Health, Impact Medicine, and Medical Devices. We assist startups at the pre-seed phase to create the essential elements to transition from idea to first significant fundraising. T-syte is an Israeli Healthcare Venture Lab focused on Digital Health, Impact Medicine, and Medical Devices. We assist startups at the pre-seed phase to create the essential elements to transition from idea to first significant fundraising.



8400 The Health Network

• Israel
• Hospitals and Health Care
• 1 - 100 Employee

• Member, Cohort #3

  • Jan 2020 - Present



BioMedical

• Tel Aviv Area, Israel

• Physician and a Biomedical R&D

  • 2018 - Present



Cordio Medical Ltd

• Tel Aviv Area, Israel

• Co-Founder

  • Jul 2013 - Present

  Cordio Medical provides groundbreaking solution for monitoring CHF patients, through free speech into a smartphone app. Cordio Medical technology features a multi-layer voice analysis workflow that indicate changes in CHF patient's lungs fluids anatomy. A simple smartphone app at the front end with a sophisticated cluster of proprietary algorithms at the back-end allow near real-time monitoring of patients and early alerts on deterioration. Cordio Medical provides groundbreaking solution for monitoring CHF patients, through free speech into a smartphone app. Cordio Medical technology features a multi-layer voice analysis workflow that indicate changes in CHF patient's lungs fluids anatomy. A simple smartphone app at the front end with a sophisticated cluster of proprietary algorithms at the back-end allow near real-time monitoring of patients and early alerts on deterioration.



RAD BioMed

• Israel
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Senior Medical Officer

  • Jun 2017 - Apr 2018

  RAD BioMed is an accelerator for Israeli life science startups ‘de-risking’ the start-up process with comprehensive support to turn breakthrough technologies into commercial products. RAD BioMed is an accelerator for Israeli life science startups ‘de-risking’ the start-up process with comprehensive support to turn breakthrough technologies into commercial products.



Xerem Medical

• Tel Aviv Area, Israel

• CEO

  • Apr 2015 - Apr 2017

  Xerem Medical is developing a novel vascular access using the bone marrow as vascular tissue per se. This is for home dialysis users and chronic IV at-home infusion. Xerem Medical is developing a novel vascular access using the bone marrow as vascular tissue per se. This is for home dialysis users and chronic IV at-home infusion.



Bioexecutive Forum

• Tel Aviv

• Management Committee Member

  • Jun 2014 - Jun 2016

  The BioExecutive Forum is a non-for-profit organization creating opportunities to the Israeli life science executives by blending knowledge, networking and inspiration. http://www.meetup.com/BioExecutive-Forum/ Identifying and recruiting volunteer speakers to each of the Forum meetings, to provide know-how, inspiration and news update to the BioExecutive attendees. The BioExecutive Forum is a non-for-profit organization creating opportunities to the Israeli life science executives by blending knowledge, networking and inspiration. http://www.meetup.com/BioExecutive-Forum/ Identifying and recruiting volunteer speakers to each of the Forum meetings, to provide know-how, inspiration and news update to the BioExecutive attendees.



RAD BioMed

• Israel
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Chief Medical Officer and scouting

  • Apr 2011 - Apr 2015

  Early stage device / drug development is a challenging task. Lean incubator companies can use as much support as possible and I am fortunate to be there for them at this special time to provide it. Early stage device / drug development is a challenging task. Lean incubator companies can use as much support as possible and I am fortunate to be there for them at this special time to provide it.



Novartis Consumer Health GmbH

• Germany
• 1 - 100 Employee

• Associate Director Clinical Research

  • Jul 2007 - Aug 2009

  Design and performance of clinical studies, phases I and IV, pharmacokinetic and safety trials, performed in the US and globally, NDA submission to the FDA Design and performance of clinical studies, phases I and IV, pharmacokinetic and safety trials, performed in the US and globally, NDA submission to the FDA



Icahn School of Medicine at Mount Sinai

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Senior Researcher

  • May 2006 - Jun 2007

  Studying tumor suppressors in various cancer models. PI - Prof Goutham Narla. Providing guidance for junior researchers and students Studying tumor suppressors in various cancer models. PI - Prof Goutham Narla. Providing guidance for junior researchers and students



Icahn School of Medicine at Mount Sinai, Department of Liver disease

• Greater New York City Area

• Post Doctoral fellow

  • Jul 2003 - May 2006

  Studying the role of a new tumor suppressor gene in cancer in various mouse models. PI - Prof Scott L Friedman Studying the role of a new tumor suppressor gene in cancer in various mouse models. PI - Prof Scott L Friedman



Rabin Medical Center

• Tel Aviv Area, Israel

• Internal Medicine Resident

  • Sep 1998 - Jun 2003